Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-17

Clinical Trial Update: Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on GMI-1271 in combination with chemotherapy for acute myeloid leukemia (AML) completed Phase 1/2 studies to assess safety, pharmacokineti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GMI-1271 (GMI-1271)

Snippet

Sponsor: GlycoMimetics Incorporated | Conditions: Leukemia, Myeloid, Acute | Phase 1, Phase 2 | Status: COMPLETED